Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Deloitte
Cantor Fitzgerald
McKesson
Johnson and Johnson
Farmers Insurance
Healthtrust
US Department of Justice

Generated: September 22, 2018

DrugPatentWatch Database Preview

Duramed Pharms Barr Company Profile

« Back to Dashboard

What is the competitive landscape for DURAMED PHARMS BARR, and what generic and branded alternatives to DURAMED PHARMS BARR drugs are available?

DURAMED PHARMS BARR has sixty-eight approved drugs.



Summary for Duramed Pharms Barr
US Patents:0
Tradenames:34
Ingredients:30
NDAs:68

Drugs and US Patents for Duramed Pharms Barr

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Duramed Pharms Barr METHYLPREDNISOLONE methylprednisolone TABLET;ORAL 088497-001 Feb 21, 1984 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Duramed Pharms Barr DIAZEPAM diazepam TABLET;ORAL 070896-001 Aug 27, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Duramed Pharms Barr OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride CAPSULE;ORAL 040289-001 Mar 16, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Duramed Pharms Barr GYNODIOL estradiol TABLET;ORAL 040212-003 Dec 29, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Merck
Chinese Patent Office
McKinsey
Johnson and Johnson
US Department of Justice
Daiichi Sankyo
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.